Stimcell Energetics (STME) Operating Margin Growth (3y) (2019 - 2023)

Stimcell Energetics (STME) Operating Margin Growth (3y) (2019 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -343.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 17.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 78.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -283.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,505.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2,016.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -184.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Stimcell Energetics 5.85 Mn 5.84 Mn - -

Historic Data

Download Data
DateValue
May 31, 2023 -8.72 Mn
Feb 28, 2023 -3.70 Mn
Nov 30, 2022 -1.33 Mn
Aug 31, 2022 -2.69 Mn
Feb 29, 2020 4.63 Mn
Nov 30, 2019 6.90 Mn
Aug 31, 2019 361,674.00